Key points are not available for this paper at this time.
These findings indicate that localized production of IL-22 in the liver promotes hepatocyte survival and proliferation but primes the liver to be more susceptible to tumor development without significantly affecting liver inflammation.
Park et al. (Mon,) studied this question.